'Tremendous uncertainty' for cancer research as US gov target mRNA vaccines
10 months ago
- #public health
- #cancer research
- #mRNA vaccines
- US regulators and independent advisers are scrutinizing mRNA vaccines, raising concerns about potential impacts on cancer research.
- mRNA vaccines show promise in treating difficult cancers like pancreatic cancer and brain tumors, with over 120 clinical trials underway.
- Federal and state actions, including funding cuts and restrictions, threaten to stall mRNA vaccine research and development.
- Scientists fear that the backlash against mRNA vaccines could hinder progress in therapeutic cancer vaccines and other medical breakthroughs.
- Early trials indicate mRNA vaccines could significantly reduce cancer recurrence, with personalized vaccines offering new treatment paradigms.
- Federal and state policies, including bans and funding cuts, are creating uncertainty and discouraging new research initiatives.
- Despite challenges, researchers remain optimistic about the transformative potential of mRNA vaccines in treating cancer and other diseases.